Document is current
Any future updates will be listed below
-
Authors
Davyson, E. https://orcid.org/0000-0002-7313-0530
Shen, X. https://orcid.org/0000-0002-0538-4774
Huider, F. https://orcid.org/0000-0001-7776-7988
Adams, M. J. https://orcid.org/0000-0002-3599-6018
Borges, K.
McCartney, D. L. https://orcid.org/0000-0003-3242-0360
Barker, L. F. https://orcid.org/0000-0003-3356-5625
van Dongen, J.
Boomsma, D. I. https://orcid.org/0000-0002-7099-7972
Weihs, A. https://orcid.org/0000-0002-7113-0027
Grabe, H. J.
Kühn, L. https://orcid.org/0000-0002-0158-8286
Teumer, A. https://orcid.org/0000-0002-8309-094X
Völzke, H.
Zhu, T.
Kaprio, J. https://orcid.org/0000-0002-3716-2455
Ollikainen, M. https://orcid.org/0000-0003-3661-7400
David, F. S. https://orcid.org/0000-0001-9521-5669
Meinert, S.
Stein, F.
Forstner, A. J. https://orcid.org/0000-0002-1876-6368
Dannlowski, U.
Kircher, T. https://orcid.org/0000-0002-2514-2625
Tapuc, A. https://orcid.org/0009-0001-8567-2011
Czamara, D. https://orcid.org/0000-0001-7381-904X
Binder, E. B. https://orcid.org/0000-0001-7088-6618
Brückl, T.
Kwong, A. S. F.
Yousefi, P. https://orcid.org/0000-0003-3284-3240
Wong, C. C. Y.
Arseneault, L. https://orcid.org/0000-0002-2938-2191
Fisher, H. L. https://orcid.org/0000-0003-4174-2126
Mill, J. https://orcid.org/0000-0003-1115-3224
Cox, S. R. https://orcid.org/0000-0003-4036-3642
Redmond, P.
Russ, T. C. https://orcid.org/0000-0001-9797-2188
van den Oord, E. J. C. G. https://orcid.org/0000-0003-2701-4405
Aberg, K. A. https://orcid.org/0000-0001-6103-5168
Penninx, B. W. J. H. https://orcid.org/0000-0001-7779-9672
Marioni, R. E. https://orcid.org/0000-0003-4430-4260
Wray, N. R. https://orcid.org/0000-0001-7421-3357
McIntosh, A. M. https://orcid.org/0000-0002-0198-4588
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 9 December 2024
First Online: 24 February 2025
Competing interests
: R.E.M. is an advisor to the Epigenetic Clock Development Foundation and Optima Partners. D.L.M. was employed by Optima Partners Ltd in a part-time capacity. H.J.G. has received travel grants and speaker honoraria from Fresenius Medical Care, Neuraxpharm, Servier, Indorsia and Janssen Cilag, as well as research funding from Fresenius Medical Care. H.J.G. had personal contracts approved by the university administration for speaker honoraria and one IIT with Fresenius Medical Care. T.K. received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, neuraxpharm. B.W.J.H.P. has received research funding (not related to the current paper) from Boehringer Ingelheim and Jansen Research. All other authors report no biomedical financial interests or potential conflicts of interest.
